Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
31311 | 125 | 44.1 | 89% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
520 | 14322 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//NANOSUSPENSION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | LIPID NANOCAPSULES | Author keyword | 44 | 70% | 30% | 37 |
2 | U1066 | Address | 9 | 42% | 13% | 16 |
3 | U646 | Address | 9 | 23% | 26% | 33 |
4 | IBS CHU ANGERS | Address | 7 | 67% | 5% | 6 |
5 | IBS CHU | Address | 6 | 80% | 3% | 4 |
6 | EQUIPE PYVER | Address | 4 | 67% | 3% | 4 |
7 | SCAHU | Address | 4 | 75% | 2% | 3 |
8 | LIPIDIC NANOCAPSULES | Author keyword | 3 | 100% | 2% | 3 |
9 | LIPID NANOCAPSULE | Author keyword | 3 | 50% | 3% | 4 |
10 | CIFAB PRIMEX | Address | 2 | 67% | 2% | 2 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LIPID NANOCAPSULES | 44 | 70% | 30% | 37 | Search LIPID+NANOCAPSULES | Search LIPID+NANOCAPSULES |
2 | LIPIDIC NANOCAPSULES | 3 | 100% | 2% | 3 | Search LIPIDIC+NANOCAPSULES | Search LIPIDIC+NANOCAPSULES |
3 | LIPID NANOCAPSULE | 3 | 50% | 3% | 4 | Search LIPID+NANOCAPSULE | Search LIPID+NANOCAPSULE |
4 | EXTRA MAMMARY | 2 | 67% | 2% | 2 | Search EXTRA+MAMMARY | Search EXTRA+MAMMARY |
5 | INTRA CAROTID INJECTION | 2 | 67% | 2% | 2 | Search INTRA+CAROTID+INJECTION | Search INTRA+CAROTID+INJECTION |
6 | LONG CIRCULATING NANOCARRIERS | 2 | 67% | 2% | 2 | Search LONG+CIRCULATING+NANOCARRIERS | Search LONG+CIRCULATING+NANOCARRIERS |
7 | POST INSERTION | 2 | 36% | 3% | 4 | Search POST+INSERTION | Search POST+INSERTION |
8 | STEALTH PROPERTIES | 2 | 43% | 2% | 3 | Search STEALTH+PROPERTIES | Search STEALTH+PROPERTIES |
9 | 9L TUMOUR MODEL | 1 | 100% | 2% | 2 | Search 9L+TUMOUR+MODEL | Search 9L+TUMOUR+MODEL |
10 | AMPHIPHILIC PHOSPHOLIPIDS | 1 | 100% | 2% | 2 | Search AMPHIPHILIC+PHOSPHOLIPIDS | Search AMPHIPHILIC+PHOSPHOLIPIDS |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | LIPID NANOCAPSULES | 3 | 23% | 10% | 12 |
2 | LOADED LIPID NANOCAPSULES | 1 | 50% | 2% | 2 |
3 | DIFFERENT FLUID INTERFACES | 1 | 50% | 1% | 1 |
4 | RE 188 DIMERCAPTOSUCCINIC ACID | 1 | 50% | 1% | 1 |
5 | CHITOSAN NANOCAPSULES | 0 | 33% | 1% | 1 |
6 | INTRAARTERIAL CARBOPLATIN | 0 | 33% | 1% | 1 |
7 | SOFT PARTICLE | 0 | 17% | 2% | 2 |
8 | CORE NANOCAPSULES | 0 | 25% | 1% | 1 |
9 | PARTICLE ELECTROPHORESIS THEORY | 0 | 25% | 1% | 1 |
10 | POLYMERIC NANOCARRIERS | 0 | 25% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Lipid nanocapsules: A new platform for nanomedicine | 2009 | 118 | 73 | 36% |
Gene therapy and DNA delivery systems | 2014 | 34 | 161 | 3% |
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab' fragments | 2007 | 44 | 32 | 16% |
Glioblastoma Multiforme and Lipid Nanocapsules: A Review | 2015 | 0 | 155 | 27% |
PEGylated Lipid Nanocapsules with Improved Drug Encapsulation and Controlled Release Properties | 2014 | 1 | 42 | 21% |
Developments in the use of nanocapsules in oncology | 2013 | 1 | 87 | 22% |
Toward an effective strategy in glioblastoma treatment. Part II: RNA interference as a promising way to sensitize glioblastomas to temozolomide | 2015 | 0 | 73 | 8% |
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting | 2010 | 47 | 188 | 3% |
Methods for the Functionalisation of Nanoparticles: New Insights and Perspectives | 2010 | 20 | 78 | 4% |
Extra-mammary findings on breast MRI: a pictorial review | 2015 | 0 | 17 | 6% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | U1066 | 9 | 42% | 13% | 16 |
2 | U646 | 9 | 23% | 26% | 33 |
3 | IBS CHU ANGERS | 7 | 67% | 4.8% | 6 |
4 | IBS CHU | 6 | 80% | 3.2% | 4 |
5 | EQUIPE PYVER | 4 | 67% | 3.2% | 4 |
6 | SCAHU | 4 | 75% | 2.4% | 3 |
7 | CIFAB PRIMEX | 2 | 67% | 1.6% | 2 |
8 | HLTH SANTIAGO COMPOSTELA IDIS | 1 | 50% | 1.6% | 2 |
9 | INSERM MINT MICRO NANOMED BIOMIMET U1066 | 1 | 100% | 1.6% | 2 |
10 | MINT MICRO NANOMED BIOMIMET U1066 | 1 | 100% | 1.6% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000236501 | NANOCAPSULES//LIPID CORE NANOCAPSULES//POLYALKYLCYANOACRYLATE |
2 | 0.0000193652 | NANO EMULSIONS//NANOEMULSION//EMULSIFICATION EVAPORATION |
3 | 0.0000175642 | SOLID LIPID NANOPARTICLES//NANOSTRUCTURED LIPID CARRIERS//SOLID LIPID NANOPARTICLE |
4 | 0.0000143051 | ACCELERATED BLOOD CLEARANCE ABC PHENOMENON//ANTI PEG IGM//ABC PHENOMENON |
5 | 0.0000142837 | CANCER NANOTECHNOLOGY//NANOSCI NANOENGN INITIAT NUSNNI//CHEMOTHERAPEUTIC ENGINEERING |
6 | 0.0000139279 | LIPOSOMAL CISPLATIN//LIPOPLATIN//SPI 077 |
7 | 0.0000125695 | NAB PACLITAXEL//CREMOPHOR EL//NEW MAT BIOL |
8 | 0.0000119659 | CONVECTION ENHANCED DELIVERY//GLIADEL//CARMUSTINE WAFERS |
9 | 0.0000110134 | BRAIN TARGETING//SMART DRUG DELIVERY//ANGIOPEP 2 |
10 | 0.0000090271 | TUMOR TROPISM//MOL NEUROTHER Y IMAGING//VET BIOCHEM IMMUNOL |